FDA — authorised 26 April 1972
- Application: ANDA080750
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: OINTMENT — TOPICAL
- Status: approved
🇺🇸 Dose control for Arm B in United States
FDA authorised Dose control for Arm B on 26 April 1972
Marketing authorisations
FDA — authorised 28 April 1972
- Application: ANDA080745
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 24 July 1972
- Application: ANDA083016
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 26 July 1972
- Application: ANDA083015
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 26 July 1972
- Application: ANDA083017
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 1 October 1984
- Application: ANDA088780
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 5 October 1984
- Application: ANDA088781
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT A
- Indication: OINTMENT — TOPICAL
- Status: approved
Frequently asked questions
Is Dose control for Arm B approved in United States?
Yes. FDA authorised it on 26 April 1972; FDA authorised it on 28 April 1972; FDA authorised it on 24 July 1972.
Who is the marketing authorisation holder for Dose control for Arm B in United States?
ASTELLAS holds the US marketing authorisation.